tracheloside has been researched along with Adenocarcinoma of Lung in 1 studies
*Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
An, H; Bai, X; Guo, S; Kang, X; Li, S; Liu, X; Shi, S | 1 |
1 other study(ies) available for tracheloside and Adenocarcinoma of Lung
Article | Year |
---|---|
Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma.
Topics: 4-Butyrolactone; Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Doxorubicin; Glucosides; Humans; Lung Neoplasms; Molecular Docking Simulation | 2022 |